Postoperative Nausea and Vomiting Clinical Trial
Official title:
Aromatherapy for Postoperative Nausea and Vomiting in Children: A Single Blind Randomized Clinical Trial
Postoperative nausea and vomiting (PONV) is one of the most common postoperative complications of general anesthesia in pediatrics. Pediatric rates of nausea and vomiting are approximately double those of adult patients. Aromatherapy has recently been shown to reduce PONV in adults, but the effect in paediatric patients is unknown. The goal of this study is to determine the feasibility of a large-scale study in the paediatric population.
Postoperative nausea and vomiting (PONV) is one of the most common postoperative
complications of general anesthesia occurring after up to 40% of general anesthetics. PONV
is an unpleasant experience and can result in secondary complications including wound
dehiscence, electrolyte abnormalities and aspiration pneumonia. PONV often causes delayed
stays in the postanesthesia care unit and delayed hospital discharge.
The mechanism of PONV is poorly understood. Given the multifactorial nature of nausea and
vomiting, standard pharmacological therapy approaches the problem from various pathways.
Methods that include antihistaminic therapies such as dimenhydrinate (gravol),
antiserotonergic medications such as ondansetron (Zofran) and glucocorticoids
(dexamethasone), have been used effectively in different surgical settings to address PONV.
They do not work however, without occasional significant side effects such as urinary
retention, blurred vision, increased infection rates, headaches and constipation. Given that
pharmacological interventions for PONV are not universally effective and have accompanying
side effects, there has been recent interest in additional complementary interventions.
Aromatherapy has been used to treat nausea from motion sickness, pregnancy, cancer and pain.
In postoperative adults, a recent large adequately powered randomized control trial found
aromatherapy resulted in a significant risk reduction of nausea (0.37) when compared with
saline. Given the encouraging results of the first adequately powered adult study, the goal
is to determine whether PONV is reduced by aromatherapy in the pediatric population. Thus,
the primary aim of this study is to determine if aromatherapy is more effective than placebo
in the treatment of postoperative nausea in children as a complementary treatment to current
postoperative practices.
This research is important as it is the first study to assesses whether aromatherapy can be
useful in postoperative nausea treatment for children. The implications of this study could
mean an improvement in the health care experience of children who have nausea postoperation
and potentially a reduction in rescue antinausea drug use in this population in the future.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04466046 -
The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
|
||
| Completed |
NCT03139383 -
Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery
|
N/A | |
| Recruiting |
NCT04069806 -
Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section
|
N/A | |
| Completed |
NCT04043247 -
Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting
|
N/A | |
| Terminated |
NCT01975727 -
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
|
Phase 2 | |
| Completed |
NCT03662672 -
Rib Raising for Post-operative Ileus
|
N/A | |
| Completed |
NCT00090155 -
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
|
Phase 3 | |
| Recruiting |
NCT05375721 -
Prevention of PONV With Traditional Chinese Medicine
|
N/A | |
| Completed |
NCT02480088 -
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
|
Phase 4 | |
| Recruiting |
NCT06137027 -
Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting
|
Early Phase 1 | |
| Not yet recruiting |
NCT05529004 -
A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy
|
Phase 2 | |
| Completed |
NCT02944942 -
Risk Factors for Postoperative Nausea/Vomiting
|
N/A | |
| Recruiting |
NCT02571153 -
Low Doses of Ketamine and Postoperative Quality of Recovery
|
Phase 4 | |
| Completed |
NCT02449291 -
Study of APD421 as PONV Treatment (no Prior Prophylaxis)
|
Phase 3 | |
| Completed |
NCT02550795 -
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
|
N/A | |
| Recruiting |
NCT01442012 -
Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
|
N/A | |
| Completed |
NCT01478165 -
Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting
|
N/A | |
| Unknown status |
NCT01268748 -
Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain
|
N/A | |
| Completed |
NCT02143531 -
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
|
Phase 4 | |
| Completed |
NCT00734929 -
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
|
Phase 4 |